Mad Money w/ Jim Cramer

Netflix’s Earnings Rebound, Surveying the Airline Stocks, and BioMarin CEO 10/19/22

Oct 19, 2022
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
The Spies: A Bizarre Dichotomy
01:45 • 2min
3
The Top-Down Director's View on the Fed's Race Rates
03:22 • 1min
4
The Fed Cares About Inflation
04:43 • 5min
5
The Cost of a Four-Year College
10:11 • 3min
6
Netflix's Comeback
13:20 • 6min
7
Netflix Stock Soaring 13% Today
19:20 • 4min
8
Delta Air's Earnings Beat
22:51 • 5min
9
The Strength of Air Travel: A New Normal
27:54 • 2min
10
Orphan Drug Status and the New Regulations on Medicare
30:11 • 2min
11
Rotavian: A Transformative Therapy for Hemophilia
31:55 • 2min
12
Biomere Indirect: A Revolution in Enzyme Replacement Therapy
34:11 • 2min
13
The Future of Cardiomyopathy Hypertrophic Parvial Marketing
36:21 • 2min
14
Carnival Cruise Line
37:52 • 2min
15
The Long-Term Position of Carnival Cruise Lines
39:51 • 2min
16
The Stock Exchange's Lightning Round
41:32 • 2min
17
The Mother of All Crashes
43:28 • 5min